Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pan-Ultrashort BLSZ Regimen for Pulmonary TB
NCT06905522Phase 3Recruiting
- Sponsor
- Shenzhen Third People's Hospital
- Start
- Jun 2025
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bedaquiline, linezolid, sitafloxacin, pyrazinamide in pulmonary tuberculosis (TB), sponsored by Shenzhen Third People's Hospital. Started Jun 2025; status: recruiting.
02
Drugs
bedaquilinelinezolidsitafloxacinpyrazinamide
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT06905522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06905522.